📈 AOD-9604 Protocol

Educational purposes only — not medical advice.

⸻

Lesson 1: What Is AOD-9604?

AOD-9604 is a modified fragment of human growth hormone, based around the 177–191 region.

Researchers study it for:

✅ Fat metabolism signaling
✅ Lipolysis research
✅ Metabolic health research
✅ Body composition support research

It is not the same as full HGH and is not known to raise IGF-1 like growth hormone. Early animal studies suggested effects on fat oxidation and lipolysis.  

⸻

Lesson 2: What Makes It Different?

AOD-9604 was designed to study the fat-metabolism portion of HGH without the broader growth-promoting effects of full HGH.

Simple version:

HGH = broad growth hormone effects
AOD-9604 = focused fat-metabolism research fragment

Human results have been mixed, and it is not FDA-approved for weight loss or any medical treatment.  

⸻

Lesson 3: Common Protocols

1. The Standard Daily Protocol (The Core Consensus)

The overwhelming majority of peptide bloggers and longevity clinics settle on a consistent, daily micro-dose for fat loss and metabolic support.

  • Daily Dosage: 250 mcg to 300 mcg injected subcutaneously once per day.

  • Duration: Typically run in a cycle of 12 to 20 weeks. The community notes that AOD-9604 takes time to build momentum, with noticeable body composition shifts generally appearing around week 4 to 6.

  • The "5 On, 2 Off" Variant: Some bloggers advocate for injecting 300 mcg daily for 5 consecutive days followed by 2 days off each week to prevent any theoretical receptor downregulation, though many stick to straight daily administration.

2. The Accelerated / Higher-Weight Protocol

For individuals with a higher starting body mass index or those looking for a more aggressive fat loss push, bloggers often discuss a dual-dose or elevated daily schedule.

  • Daily Dosage: 500 mcg per day total.

  • How it's split: * Option A: A single 500 mcg injection first thing in the morning.

    • Option B: Two separate 250 mcg injections—one in the morning and one in the afternoon (ensuring both are done on an empty stomach).

  • Duration: Run for a shorter 8 to 12-week cycle, followed by a 4-week washout period.

Many research protocols use AOD-9604 once daily, often done on empty stomach

⸻

Lesson 4: When To Increase

Researchers may consider increasing only when:

✅ The starting amount is tolerated
✅ No unusual GI issues occur
✅ No headaches or water-retention-type symptoms appear
✅ Body composition response has stalled
✅ Nutrition and activity are already consistent

A simple rule:

Do not increase AOD to fix poor diet, poor movement, or inconsistency.

⸻

Lesson 5: When To Stop Increasing

Stop increasing when:

* Desired research response is reached
* No additional benefit is noticed
* Side effects appear
* Higher amounts feel no better than lower amounts
* Cost outweighs results

For many researchers, the best approach is the lowest effective amount, not chasing the highest amount.

⸻

Lesson 6: Common Side Effects To Watch For

AOD-9604 is often described as well tolerated in research settings, but side effects can still occur. Reported or commonly watched issues include:

* Headache
* Nausea
* GI discomfort
* Injection-site irritation
* Water retention
* Fatigue
* Dizziness
* Sensitivity reactions

Clinical safety data has been discussed as generally favorable, but effectiveness in larger human obesity trials was not strong enough for approval.  

⸻

Prime Labs Key Takeaway

AOD-9604 is best understood as a fat-metabolism research fragment, not a GLP-1 and not full HGH.

Start low, assess tolerance, and do not keep increasing if results are not improving.

🌐 PrimeLabZone.com — Free Education Library